In Re Patrick H. O'farrell, Barry A. Polisky and David H. Gelfand
Court of Appeals for the Federal Circuit
1Opinion of the Court
RICH, Circuit Judge.
This appeal is from the decision of the United States Patent and Trademark Office Board of Patent Appeals and Interferences (board) affirming the patent examiner’s final rejection of patent application Serial No. 180,424, entitled “Method and Hybrid Vector for Regulating Translation of Het-erologous DNA in Bacteria.” The application was rejected under 35 U.S.C. § 103 on the ground that the claimed invention would have been obvious at the time the invention was made in view of a published paper by two of the three coinventors, and a publication by Bahl, Marians & Wu, 1 Gene…
2Cases cited16 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Hybritech Incorporated v. Monoclonal Antibodies, Inc.Court of Appeals for the Federal Circuit · 1986
- Panduit Corporation v. Dennison Manufacturing Co.Court of Appeals for the Federal Circuit · 1987
- Lindemann Maschinenfabrik Gmbh v. American Hoist and Derrick Company, Harris Press and Shear Division, Commercial Metals CompanyCourt of Appeals for the Federal Circuit · 1984
- Custom Accessories, Inc. v. Jeffrey-Allan Industries, Inc.Court of Appeals for the Federal Circuit · 1986
11 more not listed; retrieve them via the Exa API.
3Cited by126 opinions
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- The Regents of the University of California v. Eli Lilly and CompanyCourt of Appeals for the Federal Circuit · 1997
- Amgen, Inc., Plaintiff/cross-Appellant v. Chugai Pharmaceutical Co., Ltd., and Genetics Institute, Inc.Court of Appeals for the Federal Circuit · 1991
- Eurand, Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2012
- Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2009
121 more not listed; retrieve them via the Exa API.